American Testosterone Clinic for Men

Reading Time: < 1 minuteLow Testosterone (Hypogonadism) - Part 2 Low Testosterone in Men (Hypogonadism) with Dr. Richard Bebb - Part 2. Live video from our Public Forum on Men's Health which took place Nov. 18, 2009 at Vancouver General Hospital.From:aboutmenshealthViews:4908 0ratingsTime:07:14More inPeople Blogs Go here to see the original: Low Testosterone (Hypogonadism) - Part 2 - Video … Read more »

Reading Time: < 1 minuteHypogonadism Treatment and Symptoms XXXXXX◄ Hypogonadism treatment mdash; Finding the right information about Hypogonadism treatment symptoms, is crucial to managing Hypogonadism. Learn more about the best current treatment for you.► XXXXXXX Website: http://www.MainMD.com Provides valuable health information, tools for managing your health, and support to those who seek information. You can trust that our content is timely and credible. Discussions http://www.MainMD.com YouTube: http://www.YouTube.com Facebook: http://www.Facebook.com Twitter: http://www.Twitter.com THIS VIDEO CAN NOT BE RE-UPLOADED OR USED IN ANY WAY WITHOUT WRITTEN PERMISSION FROM MAINMD PRODS -MainMD All Rights Reserved- By: MainMDcom Read this article: Hypogonadism ¦ Treatment and Symptoms … Read more »

Reading Time: < 1 minuteMale hypogonadism Prof Ossama Fouda Male hypogonadism Prof Ossama Fouda. By: mansvu See original here: Male hypogonadism Prof Ossama Fouda - Video … Read more »

Reading Time: < 1 minuteHypogonadism - what should you do Dr. Richard Bebb is a Clinical Assistant Professor of Endocrinology and Metabolism at the University of British Columbia. By: aboutmenshealth Visit link: Hypogonadism - what should you do - Video … Read more »

Reading Time: < 1 minuteLow Testosterone (Hypogonadism) - Part 3 Low Testosterone in Men (Hypogonadism) with Dr. Richard Bebb - Part 3. Live video from our Public Forum on Men's Health which took place Nov. 18, 2009 at Van... By: aboutmenshealth More here: Low Testosterone (Hypogonadism) - Part 3 - Video … Read more »

Reading Time: < 1 minuteNURS805 Hypogonadism Lecture NURS805. By: ctelt fhsu View original post here: NURS805 Hypogonadism Lecture - Video … Read more »

Reading Time: 2 minutesGlendale, CA (PRWEB) December 15, 2013 Audio-Digest Foundation announces the release of Oncology Volume 04, Issue 16: Highlights from Future Directions: Palliative Medicine and Supportive Oncology. The goal of this program is to improve the palliative management of symptoms associated with cancer and its treatment. After hearing and assimilating this program, the clinician will be better able to: 1. Diagnose and treat hypogonadism in patients with cancer. 2. Recognize the role of hypogonadism in metabolic syndrome. 3. Select the most effective treatments available for patients with symptoms due to malignant bowel obstruction. 4. Anticipate specific adverse effects (AEs) associated with … Read more »

Reading Time: 2 minutesby Culley C. Carson III, MD Hypogonadism is defined as deficient or absent male gonadal function that results in insufficient testosterone secretion. Hypogonadism may be primary due to testicular failure, or secondary due to hypothalamic-pituitary axis dysfunction, resulting in the production or release of insufficient testosterone to maintain testosterone-dependent functions and systems. Hypogonadism can also result from a combination of testicular failure and hypothalamic-pituitary axis dysfunction. Hypogonadism affects an estimated 4 to 5 million men in the United States, and although it may occur in men at any age, low testosterone levels are especially common in older males. More than … Read more »

Reading Time: < 1 minuteOverview of Testosterone Deficiency Testosterone production declines naturally with age. Low testosterone, or testosterone deficiency (TD), may result from disease or damage to the hypothalamus, pituitary gland or testicles that inhibits hormone secretion and testosterone production, and is also known as hypogonadism. Depending on age, insufficient testosterone production can lead to abnormalities in muscle and bone development, underdeveloped genitalia and diminished virility. Testosterone is the androgenic hormone primarily responsible for normal growth and development of male sex and reproductive organs, including the penis, testicles, scrotum, prostate and seminal vesicles. It facilitates the development of secondary male sex characteristics such as … Read more »

Reading Time: < 1 minuteINTRODUCTION Hypogonadism in a male refers to a decrease in either or both of the two major functions of the testes: sperm production and/or testosterone production (see "Male reproductive physiology"). These abnormalities can result from disease of the testes (primary hypogonadism) or disease of the pituitary or hypothalamus (secondary hypogonadism). The distinction between these disorders is made by measurement of the serum concentrations of luteinizing hormone (LH) and follicle stimulating hormone (FSH): The patient has primary hypogonadism if his serum testosterone concentration and/or sperm count are low and/or his serum LH and FSH concentrations are high. The patient has secondary … Read more »

Reading Time: 3 minutesMALVERN, Pa. and NEW YORK, Nov. 7, 2012 /PRNewswire/ --Auxilium Pharmaceuticals, Inc. (AUXL), a specialty biopharmaceutical company, and Pfizer Inc. (PFE) are amending their collaboration agreement for the development, commercialization and supply of XIAPEX in the European Union (EU) and certain other European and Eurasian countries (the "Collaboration Agreement"). As a result of this amendment, the Collaboration Agreement will terminate no later than April 24, 2013. Prior to the mutual termination date, the parties will continue to perform all of their obligations as described in the Collaboration Agreement. After the termination date, rights to commercialize XIAPEX and responsibility for regulatory … Read more »

Reading Time: 3 minutesTHE WOODLANDS, Texas, Nov. 13, 2012 (GLOBE NEWSWIRE) -- Repros Therapeutics Inc.(R) (RPRX) today announced financial results for the third quarter ended September 30, 2012. Liquidity and Capital Resources The Company had cash and cash equivalents of approximately $29.6 million as of September 30, 2012 as compared to $4.6 million as of December 31, 2011. On February 1, 2012, we completed a registered direct offering to certain institutional investors, including certain existing shareholders, of 2,463,537 shares of our common stock at a price per share of $4.50. Net proceeds to us, after deducting placement agent's fees and offering expenses, were … Read more »

Reading Time: < 1 minuteThe effect of hypogonadism and testosterone-enhancing therapy on alkaline phosphatase and bone mineral density Read the article: http://onlinelibrary.wiley.com/doi/10.1111/bju.12870/abstract Ali A. Dabaja, Campbell F. B... By: BJUIjournal See the original post here: The effect of hypogonadism and testosterone-enhancing therapy - Video … Read more »

Reading Time: 3 minutesMALVERN, Pa., Dec. 7, 2012 /PRNewswire/ --Auxilium Pharmaceuticals, Inc. (AUXL) today announced that executive management will participate in the Oppenheimer Annual Growth Conference to be held December 12-13, 2012 at the Waldorf Astoria Hotel in New York City. Mr. Adrian Adams, Chief Executive Officer and President, is scheduled to present an overview of the Company and its product pipeline at 2:10 p.m. ET on Thursday, December 13, 2012. (Photo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO) The presentation will also be webcast on the "For Investors" section of the Auxilium website under the "Events" tab on December 13, 2012. The presentation slides to be used will … Read more »

Reading Time: 2 minutesMesothelioma Lawyers raising awareness of new drug that could help improve the health of mesothelioma patients. Dallas, TX (PRWEB) December 17, 2012 "This is another step forward in the medical battle against mesothelioma," said John Langdoc, mesothelioma lawyer at Baron and Budd. "Patients and caregivers need to be aware of these newer developments and we are proud to assist in the awareness process." Currently, mesothelioma doctors typically use a multi-modal approach of surgery, radiation and chemotherapy treatment. The combination of treatments is quite aggressive, and can lead to adverse side affects such as nausea, vomiting, and weight loss. Researchers recently … Read more »

Reading Time: < 1 minuteHYPOGONADISM What is testosterone? Testosterone is the male hormone which is mainly produced by the testis. Small quantities are made in other organs (eg adrenal gland), but in a man this contributes only a small amount of the total. Testosterone is a hormone which is released into the blood which will have effects on other parts of the body. Testosterone is important for: When men have a lack of testosterone the condition is termed hypogonadism What controls the production of testosterone from the testis ? PICTURE A part of the brain called the pituitary release a hormone called lutenising hormone … Read more »

Reading Time: 2 minutesby Dr. Angela DeRosa, DeRosa Medical / Special to azfamily.com azfamily.com Posted on December 9, 2013 at 11:26 AM Updated Tuesday, Dec 10 at 3:11 AM PHOENIX -- Good hormonal balance is critical to maintaining good health. When levels of key hormones in the body begin to fall, the door is opened for disease to develop. While levels fall naturally as we age, some medications like antidepressants, oral contraceptives, some beta blockers, steroids and pain killers can cause testosterone levels to plummet. For instance, testosterone drives many metabolic functions, effecting energy levels, glucose metabolism, muscle tone, and of course its … Read more »

Reading Time: 3 minutesCHESTERBROOK, Pa., Jan. 27, 2015 /PRNewswire/ --Auxilium Pharmaceuticals, Inc. (NASDAQ: AUXL), a specialty biopharmaceutical company, announced that it held a special meeting of its stockholders today at 8:30 a.m. ET to approve matters relating to the previously announced proposed merger with Endo International plc. The proposal to adopt the amended and restated agreement and plan of merger was passed by stockholders with approximately 84 percent of outstanding shares voting in favor. Auxilium anticipates that the proposed merger transaction will close on Thursday, January 29, 2015. "As we near the anticipated close of the transaction, I would like to take a … Read more »

Reading Time: < 1 minuteLINCOLNSHIRE, Ill.--(BUSINESS WIRE)-- BioSante Pharmaceuticals, Inc. (BPAX) today announced that Stephen M. Simes, BioSantes president & CEO, will present a corporate update at the 11th Annual BIO Investor Forum hosted by the Biotechnology Industry Organization (BIO). The BIO Investor Forum, which features leading private and emerging public companies, will take place October 9-10, 2012 at the Palace Hotel in San Francisco, CA. The BIO Investor Forum is an international investor conference featuring leading private and emerging public biotech companies. Information about the conference is available at http://www.bio.org/events/conferences/11th-annual-bio-investor-forum. About BioSante Pharmaceuticals, Inc. BioSantes corporate strategy is to develop high value medically-needed … Read more »